Sorafenib treatment for advanced hepatocellular carcinoma: Effectiveness, safety, and controversial points.

Authors

null

Takayoshi Oikawa

Division of Hepatology, Depertment of Internal medicine, Iwate Medical University, Morioka, Japan

Takayoshi Oikawa , Kei Sawara , Hidekatsu Kuroda , Yasuhiro Takikawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 496)

DOI

10.1200/JCO.2017.35.4_suppl.496

Abstract #

496

Poster Bd #

N14

Abstract Disclosures

Similar Posters

First Author: N. Williet

First Author: Andrew Johns